Skip to main content

Animations

MJFF Publications

5401 - 5410 of 6255 Results
Title
Year
  • Year
  • 2019
  • 2024
  • 2016
  • 2018
  • 2023
  • 2018
  • 2019
  • 2022
  • 2021
  • 2023
  • Summary Details
    OPEN
    Title: LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-019-0679-5
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Lysosomal TBK1 responds to amino acid availability to relieve Rab7-dependent mTORC1 inhibition
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s44318-024-00180-8
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1096/fj.201600816r
    Citation Count: 356
  • Summary Details
    OPEN
    Title: The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.644
    Citation Count: 472
  • Summary Details
    OPEN
    Title: Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2023.1069411
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1286-2
    Citation Count: 81
  • Summary Details
    OPEN
    Title: Crystal structure of the WD40 domain dimer of LRRK2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.1817889116
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at 16q11.2 and MAPT H1 loci
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awac325
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Heat Shock Protein 70 as a Sex-Skewed Regulator of α-Synucleinopathy
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1007/s13311-021-01114-6
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Application of Aligned-UMAP to longitudinal biomedical studies
    Journal Name: Patterns
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.patter.2023.100741
    Citation Count: 16
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.